Chrystal M. Paulos

Emory University — United States

Medicine · Health Sciences

48h-index12.7kcitations354works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(179), Cancer Immunotherapy and Biomarkers(124), Immune Cell Function and Interaction(118), Immunotherapy and Immune Responses(113), T-cell and B-cell Immunology(58)

Publications353 total

High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma
Cancer Research·2025Open Access
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy
Cancer Immunology Research·2025Open Access
Supplementary Data from Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer
2025Open Access
Supplementary Table 1 from Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer
2025Open Access
338 Maintenance, function, and plasticity of CD8 <sup>+</sup> resident memory (TRM) cells from tumor-draining lymph nodes
Regular and Young Investigator Award Abstracts·2025Open Access
Adoptively transferred naïve CD8 T cells develop enhanced effector function and improved persistence in neoantigen tumors 4282
The Journal of Immunology·2025Open Access
22 Neoadjuvant pepinemab enhances immune checkpoint blockade in metastatic melanoma characterized by biomarkers of TME reprogramming including tertiary lymphoid structures
Regular and Young Investigator Award Abstracts·2025Open Access
Synergistic effects of CAR T cell therapy and immune checkpoint inhibition in a clinically-relevant melanoma mouse model: implications for tumor immunity 3629
The Journal of Immunology·2025Open Access
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity
UNC Libraries·2025Open Access
Development of a murine tumor-infiltrating lymphocyte therapy model for cholangiocarcinoma
The Journal of Immunology·2025· 1 citedOpen Access
Constructing the cure: engineering the next wave of antibody and cellular immune therapies
Journal for ImmunoTherapy of Cancer·2025Open Access
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity
Cancer Cell·2025· 6 citedOpen Access
Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma
Hepatology·2025· 2 citedOpen Access
Neoadjuvant biomarker trial of pepinemab to enhance nivolumab or ipilimumab activity in resectable head and neck cancer.
Journal of Clinical Oncology·2025· 1 cited
Chemokines as predictive biomarkers for immune checkpoint inhibitor (ICI) efficacy in triple negative breast cancer (TNBC).
Journal of Clinical Oncology·2025· 2 cited
Neoantigens drive adoptively transferred CD8 T cells to long-lived effectors mediated by lymph node trafficking
2025Open Access
Abstract 3975: Regulating dendritic cells to promote mature tertiary lymphoid structures and enhance anti-tumor immunity
Cancer Research·2025
Abstract 6007: Neoadjuvant pepinemab enhances DC function associated with mature tertiary lymphoid structures and activity of immune checkpoint blockade in patients with metastatic melanoma
Cancer Research·2025
High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Signatures Between Primary and Metastatic Pancreatic Ductal Adenocarcinoma
2025Open Access
MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer
Nature Communications·2025· 7 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Nicholas P. Restifo(12), Luca Gattinoni(11), Douglas C. Palmer(10), Michelle H. Nelson(10), Megan M. Wyatt(10), Hannah M. Knochelmann(9), Shikhar Mehrotra(9), Claudia Wrzesinski(8), Andrew Kaiser(8), Zihai Li(8), Mark P. Rubinstein(8), Zhiya Yu(7), Christian S. Hinrichs(7), Steven A. Rosenberg(7), Stefanie R. Bailey(7), Carl H. June(6), Pawel Muranski(6), Elizabeth Garrett‐Mayer(6), Aubrey S. Smith(6), Kinga Majchrzak(6)